Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Imafuku, Shinichi | - |
dc.contributor.author | Zheng, Min | - |
dc.contributor.author | Tada, Yayoi | - |
dc.contributor.author | Zhang, Xibao | - |
dc.contributor.author | Theng, Colin | - |
dc.contributor.author | Thevarajah, Suganthi | - |
dc.contributor.author | Zhao, Yi | - |
dc.contributor.author | Song, Hae Jun | - |
dc.date.accessioned | 2021-09-02T09:11:10Z | - |
dc.date.available | 2021-09-02T09:11:10Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-07 | - |
dc.identifier.issn | 0385-2407 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/74438 | - |
dc.description.abstract | A working group of dermatologists in Asian countries assessed the current status of psoriatic management in the region to prepare a consensus report on topical treatment in mild to moderate plaque psoriasis. Even though the association of psoriasis with systemic comorbidities is increasingly acknowledged, psoriasis is still lower in health-care priority lists in the region. The psychosocial impact of psoriasis may be greater in Asian countries due to cultural norms and social discrimination. Non-adherence to treatment is also common among Asians. The current care given to patients with mild to moderate psoriasis needs to be streamlined, enhanced and organized with a patient-centered care approach to achieve better outcomes. A comprehensive assessment of the disease severity and its impact on a patient's life is required before initiating treatment. Education and active involvement of the patient in the treatment plan is an important part of psoriatic management. It is recommended to personalize topical treatment to meet the needs of the patient, depending on disease severity, psychosocial impact, the patient's expectations and, more importantly, the patient's willingness and ability to actively follow the treatment procedure. Fixed-dose combination of corticosteroid and vitamin D analogs is the preferred topical medication for both initial and maintenance phases of treatment. The fast containment of the disease is the goal of the initial phase of 4-8 weeks and it demands a potent fast-acting topical therapy. Satisfactory control of the disease and prevention of relapses should be achieved during the maintenance phase with twice a week or weekend applications. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.subject | QUALITY-OF-LIFE | - |
dc.subject | BETAMETHASONE DIPROPIONATE | - |
dc.subject | CALCIPOTRIOL/BETAMETHASONE DIPROPIONATE | - |
dc.subject | 2-COMPOUND PRODUCT | - |
dc.subject | CLINICAL-TRIALS | - |
dc.subject | SCALP PSORIASIS | - |
dc.subject | SKIN-DISEASE | - |
dc.subject | DOUBLE-BLIND | - |
dc.subject | COMORBIDITIES | - |
dc.subject | VULGARIS | - |
dc.title | Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Song, Hae Jun | - |
dc.identifier.doi | 10.1111/1346-8138.14338 | - |
dc.identifier.scopusid | 2-s2.0-85046702306 | - |
dc.identifier.wosid | 000437296200023 | - |
dc.identifier.bibliographicCitation | JOURNAL OF DERMATOLOGY, v.45, no.7, pp.805 - 811 | - |
dc.relation.isPartOf | JOURNAL OF DERMATOLOGY | - |
dc.citation.title | JOURNAL OF DERMATOLOGY | - |
dc.citation.volume | 45 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 805 | - |
dc.citation.endPage | 811 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Dermatology | - |
dc.relation.journalWebOfScienceCategory | Dermatology | - |
dc.subject.keywordPlus | QUALITY-OF-LIFE | - |
dc.subject.keywordPlus | BETAMETHASONE DIPROPIONATE | - |
dc.subject.keywordPlus | CALCIPOTRIOL/BETAMETHASONE DIPROPIONATE | - |
dc.subject.keywordPlus | 2-COMPOUND PRODUCT | - |
dc.subject.keywordPlus | CLINICAL-TRIALS | - |
dc.subject.keywordPlus | SCALP PSORIASIS | - |
dc.subject.keywordPlus | SKIN-DISEASE | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | COMORBIDITIES | - |
dc.subject.keywordPlus | VULGARIS | - |
dc.subject.keywordAuthor | Asia | - |
dc.subject.keywordAuthor | consensus | - |
dc.subject.keywordAuthor | patient-centered care | - |
dc.subject.keywordAuthor | psoriasis | - |
dc.subject.keywordAuthor | topical therapy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.